1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck CancerOligometastatic Squamous Cell Carcinoma of the Head and NeckRecruitingPhase 32026-05-28NCT05815927